FN2 Earnings Intelligence
Cardinal Health, Inc. income statement
Cardinal Health, Inc. (CAH) Income Statement (annual) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 6/30/2021 | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2025 | 6/30/2026 est. | 6/30/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $3,407 | $4,717 | $4,043 | $5,133 | $3,874 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $162,467 | $181,364 | $205,012 | $226,827 | $222,578 | $255,866.8 | $275,628.5 |
| % Growth | 6.2% | 11.6% | 13.0% | 10.6% | -1.9% | 15.0% | 7.7% |
| Gross Profit | $6,778 | $6,545 | $6,889 | $7,414 | $8,168 | - | - |
| % Margin | 4.2% | 3.6% | 3.4% | 3.3% | 3.7% | - | - |
| EBITDA | $1,255 | $96 | $1,419 | $1,953 | $3,065 | - | - |
| % Margin | 0.8% | 0.1% | 0.7% | 0.9% | 1.4% | - | - |
| Net Income | $611 | -$933 | $261 | $852 | $1,561 | - | - |
| % Margin | 0.4% | -0.5% | 0.1% | 0.4% | 0.7% | - | - |
| Diluted EPS | $2.08 | -$3.35 | $1.00 | $3.45 | $6.45 | $10.78 | $12.07 |
| % Growth | 116.5% | -261.1% | 129.9% | 245.0% | 87.0% | 67.1% | 12.0% |
| Operating Cash Flow | $2,429 | $3,122 | $2,839 | $3,762 | $2,397 | - | - |
| CapEx | $400 | $387 | $481 | $511 | $547 | - | - |
| Free Cash Flow | $2,029 | $2,735 | $2,358 | $3,251 | $1,850 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 6/30/2021 | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2025 | 6/30/2026 est. | 6/30/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $162,467 | $181,364 | $205,012 | $226,827 | $222,578 | $255,866.8 | $275,628.5 |
| Gross Profit | $6,778 | $6,545 | $6,889 | $7,414 | $8,168 | - | - |
| EBITDA | $1,255 | $96 | $1,419 | $1,953 | $3,065 | - | - |
| Net Income | $611 | -$933 | $261 | $852 | $1,561 | - | - |
| Diluted EPS | $2.08 | -$3.35 | $1.00 | $3.45 | $6.45 | $10.78 | $12.07 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 6/30/2021 | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $3,407 | $4,717 | $4,043 | $5,133 | $3,874 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 6/30/2021 | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $2,429 | $3,122 | $2,839 | $3,762 | $2,397 |
| Capital Expenditure | $400 | $387 | $481 | $511 | $547 |
| Free Cash Flow | $2,029 | $2,735 | $2,358 | $3,251 | $1,850 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 6/30/2021 | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 6.2% | 11.6% | 13.0% | 10.6% | -1.9% |
| Gross Margin | 4.2% | 3.6% | 3.4% | 3.3% | 3.7% |
| EBITDA Margin | 0.8% | 0.1% | 0.7% | 0.9% | 1.4% |
| Net Margin | 0.4% | -0.5% | 0.1% | 0.4% | 0.7% |
| FCF Margin | 1.2% | 1.5% | 1.2% | 1.4% | 0.8% |
| Diluted EPS Growth | 116.5% | -261.1% | 129.9% | 245.0% | 87.0% |